Surveillance for Second Primary Colorectal Cancer after Adjuvant Chemotherapy: An Analysis of Intergroup 0089

Green, Robert J.; Metlay, Joshua P.; Propert, Kathleen J.; Catalano, Paul J.; Macdonald, John S.; Mayer, Robert J.; Haller, Daniel G.

doi:10.7326/0003-4819-136-4-200202190-00005

Cited by 152 publications

(100 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Because patient-specific clinical characteristics may confound the relationship between PCIE and adherence to recommended surveillance, we controlled for important factors, including the American Joint Committee on Cancer/International Union Against Cancer tumor-node-metastasis stage (derived from the PCR data and ranging from stage 0 to stage III) [28], self-reported health status (ranging from poor to excellent), treatment received (radiation therapy and systemic therapy with chemotherapy or biologics), and tendency to follow doctors' recommendations for tests to monitor their cancer (ranging from never to always) in round 1.…”

Section: Control Variablesmentioning

confidence: 99%

Patient–Clinician Information Engagement Improves Adherence to Colorectal Cancer Surveillance after Curative Treatment: Results from a Longitudinal Study

et al. 2012

View full text Add to dashboard Cite

Introduction. Follow-up surveillance after curative treatment for colorectal cancer (CRC) patients is recommended to detect early cancer recurrences and improve survival outcomes. However, a substantial proportion of CRC patients do not undergo cancer surveillance. Several demographic and disease-related factors have been associated with cancer surveillance adherence. Thus far, patientcentered communication has not been studied as a determinant for undergoing cancer surveillance. The purpose of this study is to determine whether patient-clinician information engagement (PCIE) influences patients' self-reported adherence to recommended CRC surveillance procedures.Methods. The study was a longitudinal survey among Pennsylvanian patients diagnosed with CRC in 2005. CRC patients who were eligible for surveillance and participated in both the baseline and 1-year follow-up surveys were included in this analysis (n ‫؍‬ 305). The

show abstract

Section: Control Variablesmentioning

confidence: 99%

Patient–Clinician Information Engagement Improves Adherence to Colorectal Cancer Surveillance after Curative Treatment: Results from a Longitudinal Study

et al. 2012

View full text Add to dashboard Cite

show abstract

“…Therefore, frequent colonoscopic surveillance is recommended. 37 As per the National Comprehensive Cancer Network (NCCN), colonoscopy should be repeated 1 year after surgery. Endoscopic surveillance is recommended every 3 to 5 years in this subset of patients.…”

Section: Colonoscopymentioning

confidence: 99%

Surveillance and Survivorship after Treatment for Colon Cancer

Makhoul

Alva

Wilkins

2015

Clinics in Colon and Rectal Surgery

View full text Add to dashboard Cite

Colorectal cancer is the third most common cancer diagnosed in the United States. Majority of patients have localized disease that is amenable to curative resection. Disease recurrence remains a major concern after resection. In addition, patients are at an increased risk for developing a second or metachronous colon cancer. The principal goal of surveillance following treatment of colon cancer is to improve disease-free and overall survival. Survivorship is a distinct phase following surveillance to help improve quality of life and promote longevity.

show abstract

“…The incidence of second primary invasive colorectal cancer after curative-intent treatment was approximately 0.3%/year in a carefully studied clinical trial. Many of these are low-stage lesions and thus highly curable (12).…”

Section: ------------------------------------------------------------mentioning

confidence: 99%

How initial tumor stage affects rectal cancer patient follow-up

Ode

Patel²,

Virgo³

et al. 2009

Oncol Rep

View full text Add to dashboard Cite

Abstract. Many believe that follow-up testing for rectal carcinoma patients after primary curative-intent therapy should be rather intensive for high-stage lesions and less intensive for low-stage lesions. We recently carried out a survey of the American Society of Colon and Rectal Surgeons (ASCRS) to quantify the strategies they use after primary treatment for their own patients. Considerable variability in surveillance exists. Here we report how initial TNM stage affects follow-up intensity. We devised vignettes succinctly describing otherwise healthy patients with rectal carcinoma (stages I-III). We mailed a questionnaire based on the vignettes to the 1,795 ASCRS members. Responses deemed evaluable were entered into a computer database. The effect of TNM stage on follow-up intensity for patients with stage I, II, or III rectal carcinoma treated with radical surgery was assessed by repeated-measures ANOVA. The surveillance modality most frequently utilized was the office visit. In year 1 following surgery for patients with stage I lesions, 3.8±2.7 office visits (mean ± SD) were recommended, decreasing to 1.5±1.0 in year 5. For patients with stage III lesions treated with radical surgery ± adjuvant therapy, 4.0±2.8 office visits were recommended in year 1, decreasing to 1.7±1.2 in year 5. Similar results were generated for all commonly used surveillance modalities. The intensity of follow-up after curative-intent treatment for rectal carcinoma varies minimally across TNM stages. This suggests that a controlled trial comparing high-intensity versus low-intensity follow-up testing could be carried out without stratification by TNM stage.

show abstract

Surveillance for Second Primary Colorectal Cancer after Adjuvant Chemotherapy: An Analysis of Intergroup 0089

Abstract: The incidence of second primary colorectal cancer remains high despite intensive surveillance strategies.

Cited by 152 publications

References 14 publications

Patient–Clinician Information Engagement Improves Adherence to Colorectal Cancer Surveillance after Curative Treatment: Results from a Longitudinal Study

Patient–Clinician Information Engagement Improves Adherence to Colorectal Cancer Surveillance after Curative Treatment: Results from a Longitudinal Study

Surveillance and Survivorship after Treatment for Colon Cancer

How initial tumor stage affects rectal cancer patient follow-up

Contact Info

Product

Resources

About